Physician profile
Khaled Ziada
NPI 1073520128
$53,313.78
in general payments reported to CMS, 2019-2025
17 companies · $7,713 in 2025
The $7,713 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,638 · 2020: $22.76 · 2021: $69.66 · 2022: $19K · 2023: $9,003 · 2024: $13K · 2025: $7,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Consulting Fee: $7,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $2,626 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,803.55 |
| Consulting Fee | $7,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $2,626.18 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $42,497.49 | 2022-2025 | Coroflow, Coroflow Upgrade Kit, Fielder |
| Genentech, INC. | $4,605.13 | 2019 | |
| Edwards Lifesciences Corporation | $3,250.00 | 2025 | |
| Medtronic, INC. | $2,509.56 | 2023-2025 | Resolute Onyx, Onyx Frontier, Harmony |
| Philips North America LLC | $119.05 | 2025 | Igt Devices Undivided |
| Cathworks, INC. | $76.05 | 2023 | Ffrangio |
| Recor Medical INC | $71.13 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Neovasc Medical INC | $69.66 | 2021 | |
| Angiodynamics, INC. | $45.43 | 2025 | Alphavac |
| Astrazeneca Pharmaceuticals LP | $32.39 | 2019 | |
| Acist Medical Systems, INC. | $22.76 | 2020 | |
| Abiomed | $15.13 | 2023 | Impella |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Ziada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.